Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biomedical informatics: the future for drug development.

Michael N Liebman1

  • 1Computational Biology, Abramson Cancer Center of the University of Pennsylvania, Philadelphia PA 19104, USA. liebmann@mail.med.upenn.edu

Drug Discovery Today
|January 28, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pregnancy Outcomes among Pregnant Persons after COVID-19 Vaccination: Assessing Vaccine Safety in Retrospective Cohort Analysis of U.S. National COVID Cohort Collaborative (N3C).

Vaccines·2024
Same author

Who is pregnant? Defining real-world data-based pregnancy episodes in the National COVID Cohort Collaborative (N3C).

JAMIA open·2023
Same author

Who is pregnant? defining real-world data-based pregnancy episodes in the National COVID Cohort Collaborative (N3C).

medRxiv : the preprint server for health sciences·2022
Same author

Advancing nonclinical innovation and safety in pharmaceutical testing.

Drug discovery today·2018
Same author

A clarion call to the community of current and potential journal reviewers.

Journal of translational medicine·2018
Same author

Personalized medicine: a perspective on the patient, disease and causal diagnostics.

Personalized medicine·2018
Same journal

Inorganic nanoparticles for diagnostics, drug delivery and therapy for solid tumors.

Drug discovery today·2026
Same journal

HDAC11 as a potential therapeutic target for Alzheimer's disease.

Drug discovery today·2026
Same journal

From biologics to small-molecule modulators: The evolving landscape of interleukin-targeted therapeutics.

Drug discovery today·2026
Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026
Same journal

Chemical intervention strategies targeting MYC for cancer therapy.

Drug discovery today·2026
Same journal

How many protein pairs can we chemically target?

Drug discovery today·2026
See all related articles

Drug development faces challenges like high costs and clinical trial failures. Implementing biomedical informatics can improve success rates in drug discovery and healthcare.

Area of Science:

  • Biomedical Informatics
  • Drug Development
  • Genomics

Background:

  • Drug development is hindered by limited new chemical entities, escalating costs, and clinical trial inefficiencies.
  • Pharmaceutical product launches often face withdrawal, compounded by governmental pressure to reduce drug prices.
  • The potential of genomics to significantly improve drug development processes remains largely untapped.

Purpose of the Study:

  • To review the persistent challenges in the pharmaceutical drug development pipeline.
  • To highlight the unmet potential of genomics in addressing drug development hurdles.
  • To advocate for the integration of biomedical informatics to enhance drug development and healthcare outcomes.

Main Methods:

  • Literature review of existing challenges in drug development.

Related Experiment Videos

  • Analysis of the impact of genomics on pharmaceutical research.
  • Identification of key areas within biomedical informatics for strategic implementation.

    • Main Results:

    • Persistent issues include a low number of novel drug candidates and high failure rates in late-stage clinical trials.
    • Genomic technologies have not yet fully translated into tangible improvements in drug discovery efficiency.
    • Biomedical informatics presents a critical opportunity to streamline drug development.

    Conclusions:

    • Biomedical informatics is essential for overcoming current drug development obstacles.
    • Integrating informatics solutions can lead to more successful drug discovery and improved healthcare.
    • Further development and implementation of biomedical informatics are crucial for the future of pharmaceuticals.